CLINICAL USE OF ANGIOTENSIN BLOCKING AGENTS.CASE DB.1977; NEW YORK STATE J. MED.; U.S.A.; DA. 1977; VOL. 77; NO 13; PP. 2100-2104; BIBL. 8 REF.Article

REACTIVE HYPERRENINEMIA IN RENOVASCULAR HYPERTENSION AFTER ANGIOTENSIN BLOCKADE WITH SARALASIN OR CONVERTING ENZYME INHIBITORCASE DB; LARAGH JH.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 91; NO 2; PP. 153-160; BIBL. 39 REF.Article

CONVERTING ENZYME, ANGIOTENSIN II AND HYPERTENSIVE DISEASE.LARAGH JH; SOFFER RL; CASE DB et al.1978; AMER. J. MED.; U.S.A.; DA. 1978; VOL. 64; NO 1; PP. 147-160; BIBL. 58 REF.Article

INTRAHYPNOTIC AND LONG-TERM EFFECTS OF SELF-HYPNOSIS ON BLOOD PRESSURE IN MILD HYPERTENSIONCASE DB; FOGEL DH; POLLACK AA et al.1980; INTERNATION. J. CLIN. EXPER. HYPNOS.; USA; DA. 1980; VOL. 28; NO 1; PP. 27-38; ABS. GER/FRE/SPA; BIBL. 2 P.Article

COMPARISON BETWEEN SARALASIN AND CONVERTING ENZYME INHIBITOR IN HYPERTENSIVE DISEASECASE DB; WALLACE JM; LARAGH JH et al.1979; KIDNEY INTERACTION., SUPPL.; DEU; DA. 1979; NO 9; PP. 107-114; BIBL. 20 REF.Article

A CASE OF CLOSTRIDIUM PERFRINGENS ENDOCARDITISCASE DB; GOFORTH JM; SILVA J JR et al.1972; JOHNS HOPKINS MED. J.; U.S.A.; DA. 1972; VOL. 130; NO 1; PP. 54-56; BIBL. 12REF.Serial Issue

LIMITATIONS OF TRANSCENDENTAL MEDITATION IN THE TREATMENT OF ESSENTIAL HYPERTENSION.POLLACK AA; WEBER MA; CASE DB et al.1977; LANCET; G.B.; DA. 1977; NO 8002; PP. 71-73; BIBL. 7 REF.Article

RENAL CORTICAL BLOOD FLOW AND ANGIOGRAPHY IN LOW- AND NORMAL-RENIN ESSENTIAL HYPERTENSION.CASE DB; CASARELLA WJ; LARAGH JH et al.1978; KIDNEY INTERNATION.; GERM.; DA. 1978; VOL. 13; NO 3; PP. 236-244; ABS. FR.; BIBL. 1 P. 1/2Article

UNEXPECTED PRESSOR RESPONSES TO PROPRANOLOL IN ESSENTIAL HYPERTENSION. AN INTERACTION BETWEEN RENIN, ALDOSTERONE AND SYMPATHETIC ACTIVITY.DRAYER JIM; KEIM HJ; WEBER MA et al.1976; AMER. J. MED.; U.S.A.; DA. 1976; VOL. 60; NO 6; PP. 897-903; BIBL. 16 REF.Article

CAPTOPRIL COMPARED WITH OTHER ANTIRENIN SYSTEM AGENTS IN HYPERTENSIVE PATIENTS: ITS TRIPHASIC EFFECTS ON BLOOD PRESSURE AND ITS USE TO IDENTIFY AND TREAT THE RENIN FACTORLARAGH JH; CASE DB; ATLAS SA et al.1980; HYPERTENSION (DALLAS); ISSN 0194-911X; USA; DA. 1980; VOL. 2; NO 4; PP. 586-593; BIBL. 30 REF.Article

USEFULNESS AND LIMITATIONS OF SARALASIN, A PARTIAL COMPETITIVE AGONIST OF ANGIOTENSIN II, FOR EVALUATING THE RENIN AND SODIUM FACTORS IN HYPERTENSIVE PATIENTS.CASE DB; WALLACE JM; KEIM HJ et al.1976; AMER. J. MED.; U.S.A.; DA. 1976; VOL. 60; NO 6; PP. 825-836; BIBL. 24 REF.Article

ABSENCE OF BLOOD-PRESSURE LOWERING EFFECT OF CAPTOPRIL IN ANEPHRIC PATIENTSLESLIE BR; CASE DB; SULLIVAN JF et al.1980; BRIT. MED. J.; GBR; DA. 1980; NO 6221; PP. 1067-1068; BIBL. 17 REF.Article

STUDIES OF PLASMA ALDOSTERONE IN ANEPHRIC PEOPLE: EVIDENCE FOR THE FUNDAMENTAL ROLE OF RENIN SYSTEM IN MAINTAINING ALDOSTERONE SECRETION.SEALEY JE; WHITE RP; LARAGH JH et al.1978; J. CLIN. ENDOCRINOL. METABOL.; USA; DA. 1978; VOL. 47; NO 1; PP. 52-60; BIBL. 46 REF.Article

HEMODYNAMIC EFFECTS OF THE CONVERTING ENZYME INHIBITOR TEPROTIDE IN NORMAL- AND HIGH-RENIN HYPERTENSIONNIARCHOS AP; PICKERING TG; WALLACE JM et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 5; PP. 592-601; BIBL. 44 REF.Article

USE OF FIRST-DOSE RESPONSE OR PLASMA RENIN ACTIVITY TO PREDICT THE LONG-TERM EFFECT OF CAPTOPRIL: IDENTIFICATION OF TRIPHASIC PATTERN OF BLOOD PRESSURE RESPONSECASE DB; ATLAS SA; LARAGH JH et al.1980; J. CARDIOVASC. PHARMACOL.; USA; DA. 1980; VOL. 2; NO 4; PP. 339-346; BIBL. 20 REF.Article

ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN BLOOD PRESSURE REGULATION. THE CARDIOVASCULAR EFFECTS OF CONVERTING ENZYME INHIBITION IN NORMOTHENSIVE SUBJECTSNIARCHOS AP; PICKERING TG; CASE DB et al.1979; CIRCUL. RES.; USA; DA. 1979; VOL. 45; NO 6; PP. 829-837; BIBL. 39 REF.Article

ACUTE AND CHRONIC TREATMENT OF SEVERE AND MALIGNANT HYPERTENSION WITH THE ORAL ANGIOTENSIN-CONVERTING ENZYME INHIBITOR CAPTOPRILCASE DB; ATLAS SA; SULLIVAN PA et al.1981; CIRCULATION; ISSN 0009-7322; USA; DA. 1981; VOL. 64; NO 4; PP. 765-771; BIBL. 45 REF.Article

POSSIBLE ROLE OF RENIN IN HYPERTENSION AS SUGGESTED BY RENIN-SODIUM PROFILING AND INHIBITION OF CONVERTING ENZYME.CASE DB; WALLACE JM; KEIM HJ et al.1977; NEW ENGL. J. MED.; U.S.A.; DA. 1977; VOL. 296; NO 12; PP. 641-646; BIBL. 31 REF.Article

PROTEINURIA DURING LONG-TERM CAPTOPRIL THERAPYCASE DB; ATLAS SA; MOURADIAN JA et al.1980; J.A.M.A.; USA; DA. 1980; VOL. 244; NO 4; PP. 346-349; BIBL. 18 REF.Article

THE IMMEDIATE PRESSOR RESPONSE TO SALARASIN IN MAN: A TEST OF ANGIOTENSIN II RECEPTOR VACANCYWALLACE JM; CASE DB; LARAGH JH et al.1979; CIRCUL. RES.; USA; DA. 1979; VOL. 44; NO 1; PP. 38-44; BIBL. 36 REF.Article

RENIN AND ALDOSTERONE SUPPRESSION IN THE ANTIHYPERTENSIVE ACTION OF CLONIDINE.WEBER MA; CASE DB; BAER L et al.1976; AMER. J. CARDIOL.; U.S.A.; DA. 1976; VOL. 38; NO 6; PP. 825-830; BIBL. 25 REF.Article

CLINICAL EXPERIENCE WITH BLOCKADE OF THE RENIN-ANGIOTENSINALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14, 225, CAPTOPRIL) IN HYPERTENSIVE PATIENTSCASE DB; ATLAS SA; LARAGH JH et al.1978; PROGR. CARDIOCASVUL. DIS.; USA; DA. 1978; VOL. 21; NO 3; PP. 195-206; BIBL. 21 REF.Article

HEMODYNAMIC CHARACTERISTICS OF HYPERTENSION AFTER CORONARY BYPASS SURGERY AND EFFECTS OF THE CONVERTING ENZYME INHIBITORNIARCHOS AP; ROBERTS AJ; CASE DB et al.1979; AMER. J. CARDIOL.; USA; DA. 1979; VOL. 43; NO 3; PP. 586-593; BIBL. 41 REF.Article

USE OF THE ORAL ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR (CAPTOPRIL) IN CHILDHOOD MALIGNANT HYPERTENSIONOBERFIELD SE; CASE DB; LEVINE LS et al.1979; J. PEDIATR.; USA; DA. 1979; VOL. 95; NO 4; PP. 641-644; BIBL. 11 REF.Article

A ROLE FOR RENIN IN REBOUND HYPERTENSION AND ENCEPHALOPATHY AFTER INFUSION OF SARALASIN ACETATE (SAR¹-ALA⁸-ANGIOTENSIN II).KEIM HJ; DRAYER JI; CASE DB et al.1976; NEW ENGL. J. MED.; U.S.A.; DA. 1976; VOL. 295; NO 21; PP. 1175-1177; BIBL. 9 REF.Article